- Bupivacaine Hydrochloride
-
- $0.00 / 1kg
-
2026-01-04
- CAS:73360-54-0
- Min. Order: 1kg
- Purity: 99.0% min
- Supply Ability: 1000kgs/month
|
| | Bupivacaine Hydrochloride Basic information |
| Product Name: | Bupivacaine Hydrochloride | | Synonyms: | Bupivacaine Hydrochloride (500 mg);1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride hydrate;bupivacaine hydrochloride hydrate;Bupivacaine HCl hydrate;1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride hydrate;2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, hydrochloride, hydrate (1:1:1);1-butyl-N-(2,6-dimethylphenyl)-2-Piperidinecarboxamide hydrochloride hydrate (1:1:1);Bupivacaine HCl H2O
IP/USP/BP/EP | | CAS: | 73360-54-0 | | MF: | C18H31ClN2O2 | | MW: | 342.91 | | EINECS: | 642-205-3 | | Product Categories: | API | | Mol File: | 73360-54-0.mol |  |
| | Bupivacaine Hydrochloride Chemical Properties |
| Melting point | 255-259℃ | | RTECS | TK6125000 | | storage temp. | room temp | | solubility | DMSO (Slightly), Methanol (Slightly), Water (Slightly) | | form | solid | | Water Solubility | Soluble in water to 50 mM, in DMSO to 100 mM and in ethanol to 100 mM. | | Major Application | forensics and toxicology
pharmaceutical (small molecule)
veterinary | | InChI | InChI=1S/C18H28N2O.ClH.H2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H;1H2 | | InChIKey | HUCIWBPMHXGLFM-UHFFFAOYSA-N | | SMILES | C(C1CCCCN1CCCC)(=O)NC1C(=CC=CC=1C)C.Cl.O |
| Hazard Codes | T+ | | Risk Statements | 26/27/28 | | Safety Statements | 22-36/37/39-45 | | RIDADR | UN 2811 6.1 / PGII | | WGK Germany | 3 | | HazardClass | 6.1 | | Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2
very toxic hazardous materials | | Hazard Classifications | Acute Tox. 1 Inhalation
Acute Tox. 2 Dermal
Acute Tox. 2 Oral |
| | Bupivacaine Hydrochloride Usage And Synthesis |
| Uses | It is employed as Na+ channel blocker, local anesthetic and cAMP production inhibitor. It acts as a surfactant molecule possessing both hydrophilic and lipophilic properties, adrenergic antagonist, EC 3.1.1.8 (cholinesterase) inhibitor and EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor. | | Definition | ChEBI: A racemate composed of equimolar amounts of dextrobupivacaine hydrochloride hydrate and levobupivacaine hydrochloride hydrate. A piperidinecarboxamide-based local anaesthetic, it has a slow onset and long duration of action. | | Biological Activity | Sodium channel blocker, local anesthetic. | | IC 50 | NMDA Receptor |
| | Bupivacaine Hydrochloride Preparation Products And Raw materials |
|